Home
STXS vs XBIT Comparison

STXS vs XBIT Comparison

Compare STXS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STXS

XBIT

Machine Learning Prediction

ML Decision
STXS
XBIT

Stock Information

Founded
STXS 1990
XBIT 2005

Country
STXS United States
XBIT United States

Employees
STXS N/A
XBIT N/A

Industry
STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
XBIT Pharmaceuticals and Biotechnology

Sector
STXS Health Care
XBIT Health Care

Exchange
STXS Nasdaq
XBIT Nasdaq

Market Cap
STXS N/A
XBIT 194.5M

IPO Year
STXS 2004
XBIT 2015

Fundamental

Price
STXS $2.20
XBIT $3.70

Analyst Decision
STXS Strong Buy
XBIT

Analyst Count
STXS 2
XBIT 0

Target Price
STXS $4.50
XBIT N/A

AVG Volume (30 Days)
STXS 332.0K
XBIT 84.7K

Earning Date
STXS 03-03-2025
XBIT 03-14-2025

Dividend Yield
STXS N/A
XBIT N/A

EPS Growth
STXS N/A
XBIT N/A

EPS
STXS N/A
XBIT N/A

Revenue
STXS $25,143,000.00
XBIT N/A

Revenue This Year
STXS $3.73
XBIT N/A

Revenue Next Year
STXS $54.27
XBIT N/A

P/E Ratio
STXS N/A
XBIT N/A

Revenue Growth
STXS N/A
XBIT N/A

52 Week Low
STXS $1.66
XBIT $3.51

52 Week High
STXS $3.29
XBIT $9.96

Technical

Relative Strength Index (RSI)
STXS 48.70
XBIT 30.78

Support Level
STXS $2.21
XBIT $3.64

Resistance Level
STXS $2.22
XBIT $4.00

Average True Range (ATR)
STXS 0.13
XBIT 0.28

MACD
STXS -0.01
XBIT 0.06

Stochastic Oscillator
STXS 23.23
XBIT 9.35

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: